CBPO [China Biologic Products] 8-K: FOR RELEASE November 8, 2012 China Biologic Reports

[FOR RELEASE November 8, 2012 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012 3Q12 Total Sales Up 28.6% to $53.1 Million BEIJING, China – November 8, 2012 – Third Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6698-3166 (Former name or former address,]

CBPO [China Biologic Products] 10-Q: (Original Filing)

[FORM 10 - Q (Mark One) [ X ] For the quarterly period ended: September 30, 2012 [ ] For the transition period from _____________to ______________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

TSL [Trina Solar] 6-K: (Original Filing)

[Trina Solar Statement on the International Trade Commission’s Trina Solar is currently evaluating whether it is necessary and prudent to appeal these final determinations issued by the ITC. As announced previously, we are prepared for this outcome and will continue to abide by our contractual commitments. This will not affect the offering of product lines that are not subject to] [TRINA SOLAR LIMITED]

By | 2016-03-17T11:40:40+00:00 November 8th, 2012|Categories: Chinese Stocks, SEC Original, TSL|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q: FORM 10 – Q (Mark One) [ X

[FORM 10 - Q (Mark One) [ X ] For the quarterly period ended: September 30, 2012 [ ] For the transition period from _____________to ______________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

Skip to toolbar